CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-22 | Hexter Joshua COO & CBO | Option exercise · Performance Stock Units | −19,000 | 0 | ||
| 2026-01-22 | Gabay Avraham Chief Financial Officer | Option exercise | +19,000 | 649,256 | ||
| 2026-01-22 | Gabay Avraham Chief Financial Officer | Option exercise · Performance Stock Units | −19,000 | 0 | ||
| 2026-01-14 | Kidron Miriam Chief Scientific Officer | Gift | −86,166 | 1,343,498 | ||
| 2025-12-31 | Reznick Yehuda Director | Grant or award | +30,000 | 98,930 | ||
| 2025-12-31 | Reznick Yehuda Director | Grant or award | +6,250 | 105,180 | ||
| 2025-12-31 | KIDRON NADAV President and CEO | Grant or award | +232,640 | 2,919,238 | ||
| 2025-12-31 | KIDRON NADAV President and CEO | Grant or award | +327,000 | 3,246,238 | ||
| 2025-12-31 | KIDRON NADAV President and CEO | Grant or award · Performance Stock Units | +109,000 | 109,000 | ||
| 2025-12-31 | Kidron Miriam Chief Scientific Officer | Grant or award | +121,331 | 1,314,664 | ||
| 2025-12-31 | Kidron Miriam Chief Scientific Officer | Grant or award | +115,000 | 1,429,664 | ||
| 2025-12-31 | Kidron Miriam Chief Scientific Officer | Grant or award · Performance Stock Units | +19,000 | 19,000 | ||
| 2025-12-31 | Hexter Joshua COO & CBO | Grant or award | +97,328 | 930,495 | ||
| 2025-12-31 | Hexter Joshua COO & CBO | Grant or award | +115,000 | 1,045,495 | ||
| 2025-12-31 | Hexter Joshua COO & CBO | Grant or award · Performance Stock Units | +19,000 | 19,000 | ||
| 2025-12-31 | Shapiro Benjamin Director | Grant or award | +30,000 | 119,720 | ||
| 2025-12-31 | Shapiro Benjamin Director | Grant or award | +3,500 | 123,220 | ||
| 2025-12-31 | Mayer Arie Director | Grant or award | +30,000 | 163,109 | ||
| 2025-12-31 | Mayer Arie Director | Grant or award | +4,900 | 168,009 | ||
| 2025-12-31 | Aghion Daniel Director | Grant or award | +30,000 | 107,191 |
Page 3 of 9 · 170 trades